This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Delivered as Hybrid Event from 15-17 November 2021
Live In-Person Conference Delivered 15-17 NovemberSheraton Airport Brussels, Belgium

Karina Thorn, PhD
Corporate Vice President - RNA and Gene Therapies, Global Research Technologies at Novo Nordisk

Agenda Sessions

  • Progress in Oligonucleotide Drug Development: Building the Technologies and R&D Partnerships to Accelerate Discovery